HOME › DRUGS › BOSUTINIB MONOHYDRATE
ACTIVE SUBSTANCE / INN

BOSUTINIB MONOHYDRATE

Brand name(s): BOSULIF, BOSUTINIB MONOHYDRATE, BOSUTINIB
FDA LISTED
PRESCRIPTION
NONE (TENTATIVE APPROVAL)
ANDA209577
NDA217729
ACTIVE SUBSTANCE
Bosutinib Monohydrate
REGULATORS
FDA
SPONSORS / MAH
PF PRISM CV, ALEMBIC, SUN PHARM INDUSTRIES
TOTAL APPLICATIONS
3
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
BOSUTINIBANDA209577SUN PHARM INDUSTRIESNone (Tentative Approval)
BOSUTINIB MONOHYDRATEANDA209543ALEMBICPrescription
BOSULIFNDA217729PF PRISM CVPrescription

FULL INTELLIGENCE ON BOSUTINIB MONOHYDRATE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →